Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review

BACKGROUND: Despite genetic polymorphism in response to platinum/5-Fu chemotherapy in gastric cancer (GC) has been studied, data reported so far are conflicting and critical consideration is needed before translation to the treatment of GC. METHODS: We performed a meta-analysis by using 20 eligible...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhen, Chen, Jun-qiang, Liu, Jin-lu, Qin, Xin-gan, Huang, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524027/
https://www.ncbi.nlm.nih.gov/pubmed/23020798
http://dx.doi.org/10.1186/1471-230X-12-137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524027/
https://www.ncbi.nlm.nih.gov/pubmed/23020798
http://dx.doi.org/10.1186/1471-230X-12-137

Ejemplares similares